HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease

Por Meitz, J C, Edwards, S M, Easton, D F, Murkin, A, Ardern-Jones, A, Jackson, R A, Williams, S, Dearnaley, D P, Stratton, M R, Houlston, R S, Eeles, R A
Publicado em 2002

No evidence of germline PTEN mutations in familial prostate cancer

Por FORREST, M., EDWARDS, S., HAMOUDI, R., DEARNALEY, D., ARDEN-JONES, A., DOWE, A., MURKIN, A., KELLY, J., TEARE, M, EASTON, D., KNOWLES, M., BISHOP, D, EELES, R., COLLABORATORS, T. C., COLLABORATORS, T. E.
Publicado em 2000

The role of genetic factors in predisposition to squamous cell cancer of the head and neck

Por Jefferies, S, Eeles, R, Goldgar, D, A'Hern, R, Henk, J M, Gore, M, Rhys-Evans, P, Archer, D, Bishop, K, Murkin, A, Solomon, E, Hodgsun, S, O'Connell, M, Hibbert, J, Easton, D, Foulkes, W
Publicado em 1999